Welciren-CT Softgel Capsule is a combination pharmaceutical formulation containing Calcitriol (0.25 mcg), Calcium Carbonate (500 mg), and Zinc Sulfate (7.5 mg), designed to support bone health and mineral balance. Calcitriol, the active form of vitamin D3, plays a critical role in calcium absorption and bone mineralization, making it essential in the management of conditions such as osteoporosis, hypocalcemia, and renal osteodystrophy. Calcium Carbonate serves as a vital source of elemental calcium, necessary for maintaining adequate serum calcium levels, promoting bone strength, and preventing calcium deficiency-related disorders. Zinc Sulfate contributes to enzymatic functions and supports immune health, wound healing, and skeletal development. Welciren-CT is indicated for patients requiring supplementation of these nutrients due to deficiencies, malabsorption syndromes, or increased physiological demands. The softgel formulation enhances bioavailability and patient compliance. Dosage should be individualized based on clinical assessment, serum calcium levels, and underlying conditions. Caution is advised in patients with hypercalcemia, hypervitaminosis D, or renal impairment. Regular monitoring of serum calcium and renal function is recommended during therapy. Welciren-CT Softgel Capsule should be used under medical supervision to optimize therapeutic outcomes and minimize potential adverse effects.